Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
ADAPT HER2+/HR+ trial design. HER2+/HR+ patients receive either T-DM1 monotherapy or T-DM1 in combination with endocrine therapy or Trastuzumab in combination with endocrine therapy as induction therapy according to their randomization. Randomization is only allowed after HR and HER2 status are confirmed by central pathology. The randomized regimen is applied in the neoadjuvant setting for twelve weeks followed by surgery.
